Selvita Signs a Drug Discovery Services Contract With Rottapharm Madaus

22-Jul-2010 - Poland

Rottapharm Madaus and Selvita announced signature of a services contract for delivery of drug discovery services. The aim of this project is to deliver to Rottapharm Madaus a set of designed and synthesized compounds, including their optimized synthesis route, which will have a therapeutic potential in an indicated area.

“We are delighted to start an FTE-based collaboration with Selvita. We are keen to take advantage of Selvita’s know-how to support the progression of our drug discovery pipeline" - said Luigi Stasi, Rottapharm’s Director of Medicinal Chemistry Department.

"This project is an immense chance for Selvita to show the great potential of our Computational Chemistry and Chemistry Departments. Working for Rottapharm Madaus on this project will enable us to take a full advantage of our highly skilled scientists and new facilities, and I truly believe we can deliver exactly what Rottapharm Madaus needs” - said Pawel Przewiezlikowski, Selvita’s CEO.

Other news from the department business & finance

Most read news

More news from our other portals

All FT-IR spectrometer manufacturers at a glance